American Fusion Inc., through its subsidiary, operates as an energy platform company. The company engages in the development and commercialization of fusion energy technologies. It develops Texatron, an aneutronic fusion platform which is designed to support modular, infrastructure-grade deployment for industrial, commercial, and grid-constrained applications. American Fusion Inc. was formerly known as Renewal Fuels, Inc. and changed its name to American Fusion Inc. in March 2026. The company is based in Southlake, Texas.
From Private Credit to Fusion Power: New to The Street Show #777 Premieres Tonight on Bloomberg Television
Acurx Pharmaceuticals (ACXP) appears in this release only as a paid commercial advertiser on New to The Street Show #777, a sponsored Bloomberg Television program airing tonight at 6:30 p.m. ET.
The commercial blurb reiterates existing positioning: Acurx is developing ibezapolstat as a potential first new class of antibiotics in nearly 40 years, with the FDA agreeing to consider a future application based on two planned trials, Pathfinder and Aspire.
This is sponsored promotional content issued by the media platform, which discloses it receives compensation from featured companies; it contains no new clinical, financial, or regulatory disclosure from Acurx and should be treated as low-signal noise.